0 CHECKOUT

PRODUCT FILTERS

REGION

12

CATEGORIES

  • 27
  • 15
  • 8
  • 7
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

14
15
41
74

PUBLISHED

4
9
45
74

PRODUCT TYPE

59
8
6
1

Search for: "Seattle Genetics Inc-Therapeutic Competitors"

Global Next-Generation Antibody Therapeutics Market Size, Share, Development, Growth and Demand Forecast to 2020

The global next-generation antibody therapeutics market was worth $ 1,328.3 million in 2014, and it is expected to grow at a CAGR of 44% during 2015-2020. Next-generation antibody therapeutics market...

Published:  August 2015
Price:  From

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2015

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2015 Summary The report ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2015’, provides an overview of the Anaplastic Large...

Published:  August 2015
Price:  From

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016 Summary The report ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016’, provides an overview of the Anaplastic Large...

Published:  February 2016
Price:  From

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015 Summary This, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Large Cell...

Published:  January 2015
Price:  From

Mycosis Fungoides - Pipeline Review, H2 2014

Mycosis Fungoides - Pipeline Review, H2 2014 Summary This, ‘Mycosis Fungoides - Pipeline Review, H2 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. This report provides...

Published:  October 2014
Price:  From

Mycosis Fungoides - Pipeline Review, H1 2014

Mycosis Fungoides - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mycosis Fungoides - Pipeline Review, H1 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. This...

Published:  May 2014
Price:  From

Hodgkin Lymphoma - Pipeline Review, H1 2015

Hodgkin Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline. This report provides...

Published:  January 2015
Price:  From

Burkitt Lymphoma - Pipeline Review, H2 2015

Burkitt Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Burkitt Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Burkitt Lymphoma’s therapeutic pipeline. This report provides...

Published:  December 2015
Price:  From

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015 Summary The report ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015’, provides an overview of the Graft Versus Host Disease...

Published:  September 2015
Price:  From

Burkitt Lymphoma - Pipeline Review, H1 2015

Burkitt Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Burkitt Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Burkitt Lymphoma’s therapeutic pipeline. This report provides...

Published:  May 2015
Price:  From

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016 Summary ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)...

Published:  March 2016
Price:  From

T-Cell Lymphomas - Pipeline Review, H2 2014

T-Cell Lymphomas - Pipeline Review, H2 2014 Summary This, ‘T-Cell Lymphomas - Pipeline Review, H2 2014’, provides an overview of the T-Cell Lymphomas’s therapeutic pipeline. This report provides...

Published:  October 2014
Price:  From

Seattle Genetics, Inc.

A textual analysis of the financial results for Seattle Genetics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio...

Published:  August 2015
Price:  From

Renal Cell Carcinoma - Pipeline Review, H1 2015

Renal Cell Carcinoma - Pipeline Review, H1 2015 Summary This, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline. This report...

Published:  June 2015
Price:  From

Mantle Cell Lymphoma - Pipeline Review, H1 2016

Mantle Cell Lymphoma - Pipeline Review, H1 2016 Summary The report ‘Mantle Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape. The report...

Published:  February 2016
Price:  From

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2016

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2016 Summary The report ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Metastatic Renal Cell Carcinoma...

Published:  March 2016
Price:  From

Hodgkin Lymphoma - Pipeline Review, H1 2016

Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary The report ‘Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Hodgkin Lymphoma pipeline landscape. The report provides...

Published:  February 2016
Price:  From

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016 Summary ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016’, provides an overview of the Graft Versus Host Disease (GVHD) pipeline...

Published:  March 2016
Price:  From

Mantle Cell Lymphoma - Pipeline Review, H1 2015

Mantle Cell Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This report...

Published:  January 2015
Price:  From

Seattle Genetics, Inc. (SGEN) - Financial and Strategic Analysis Review

Seattle Genetics, Inc. (Seattle) is a biotechnology company engaged in the discovery and the development of monoclonal antibody-based drugs to treat cancer and autoimmune diseases. The company's lead...

Published:  August 2010
Price:  From
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation